ZA979060B - Receptor selective BNP - Google Patents

Receptor selective BNP

Info

Publication number
ZA979060B
ZA979060B ZA979060A ZA979060A ZA979060B ZA 979060 B ZA979060 B ZA 979060B ZA 979060 A ZA979060 A ZA 979060A ZA 979060 A ZA979060 A ZA 979060A ZA 979060 B ZA979060 B ZA 979060B
Authority
ZA
South Africa
Prior art keywords
bnp
receptor selective
receptor
selective
selective bnp
Prior art date
Application number
ZA979060A
Inventor
David G Lowe
Jill R Schoenfeld
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA979060B publication Critical patent/ZA979060B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA979060A 1996-10-22 1997-10-09 Receptor selective BNP ZA979060B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73188096A 1996-10-22 1996-10-22

Publications (1)

Publication Number Publication Date
ZA979060B true ZA979060B (en) 1999-04-09

Family

ID=24941306

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA979060A ZA979060B (en) 1996-10-22 1997-10-09 Receptor selective BNP

Country Status (6)

Country Link
EP (1) EP0939770A1 (en)
JP (1) JP2001503256A (en)
AU (1) AU4816497A (en)
CA (1) CA2269656A1 (en)
WO (1) WO1998017690A1 (en)
ZA (1) ZA979060B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003297583B2 (en) 2002-11-26 2010-01-14 Biocon, Ltd Modified naturetic compounds, conjugates, and uses thereof
ES2365023T3 (en) 2004-04-21 2011-09-20 Enobia Pharma Inc. CONJUGATES OF BONE ADMINISTRATION AND METHOD OF USE OF THE SAME TO DIRECT BONE PROTEINS.
EP2658979B1 (en) 2010-12-27 2018-02-14 Alexion Pharmaceuticals, Inc. Compositions comprising natriuretic peptides and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
WO2016007873A1 (en) 2014-07-11 2016-01-14 The Regents Of The University Of Michigan Compositions and methods for treating craniosynostosis
US10449236B2 (en) 2014-12-05 2019-10-22 Alexion Pharmaceuticals, Inc. Treating seizure with recombinant alkaline phosphatase
CA2973883A1 (en) 2015-01-28 2016-08-04 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
US11352612B2 (en) 2015-08-17 2022-06-07 Alexion Pharmaceuticals, Inc. Manufacturing of alkaline phosphatases
WO2017058822A1 (en) 2015-09-28 2017-04-06 Alexion Pharmaceuticals, Inc. Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia
EP3368062A4 (en) 2015-10-30 2019-07-03 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
WO2017155569A1 (en) 2016-03-08 2017-09-14 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
CA3019726A1 (en) 2016-04-01 2017-10-05 Alexion Pharmaceuticals, Inc. Treating muscle weakness with alkaline phosphatases
WO2017173395A1 (en) 2016-04-01 2017-10-05 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
US10988744B2 (en) 2016-06-06 2021-04-27 Alexion Pharmaceuticals, Inc. Method of producing alkaline phosphatase
EP3500289B1 (en) 2016-08-18 2024-10-09 Alexion Pharmaceuticals, Inc. Asfotase alfa for use in treating tracheobronchomalacia
CN110719786A (en) 2017-03-31 2020-01-21 阿雷克森制药公司 Methods for treating Hypophosphatasia (HPP) in adults and adolescents
EP3773684A1 (en) 2018-03-30 2021-02-17 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins
CA3173631A1 (en) 2021-02-12 2022-08-18 Walter C. Voegtli Alkaline phosphatase polypeptides and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0728147B1 (en) * 1993-11-12 2003-02-12 Genentech, Inc. Receptor specific atrial natriuretic peptides

Also Published As

Publication number Publication date
WO1998017690A1 (en) 1998-04-30
EP0939770A1 (en) 1999-09-08
AU4816497A (en) 1998-05-15
CA2269656A1 (en) 1998-04-30
JP2001503256A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
IL127666A0 (en) IL-8 receptor antagonists
IL127667A0 (en) IL-8 receptor antagonists
HU9603525D0 (en) Vironectin receptor antagonists
EP0932405A4 (en) Il-8 receptor antagonists
EP1007563A4 (en) Hm74a receptor
IL128501A0 (en) IL-8 receptor antagonists
ZA979060B (en) Receptor selective BNP
EP1019035A4 (en) Il-8 receptor antagonists
EP0907362A4 (en) Il-8 receptor antagonists
EP0920417A4 (en) Il-8 receptor antagonists
IL133920A0 (en) Trail receptor
EP0929218A4 (en) P2y receptor antagonists
GB9617923D0 (en) Novel receptor
EP0923373A4 (en) Il-8 receptor antagonists
EP1084142A4 (en) Gpr35a receptor
EP0939634A4 (en) Il-8 receptor antagonists
EP0957907A4 (en) Il-8 receptor antagonists
EP0973800A4 (en) Novel receptor
EP0934066A4 (en) Il-8 receptor antagonists
EP0920253A4 (en) Il-8 receptor antagonists
EP0948330A4 (en) Il-8 receptor antagonists
GB2315286B (en) Structure
EP1083909A4 (en) hCEPR RECEPTOR
EP0859787A4 (en) G-protein coupled receptor hnfds78
EP1109565A4 (en) Gabab1aa receptor